Literature DB >> 18326156

Effect of frequency boundary assignment on speech recognition with the Nucleus 24 ACE speech coding strategy.

Marios S Fourakis1, John W Hawks, Laura K Holden, Margaret W Skinner, Timothy A Holden.   

Abstract

The choice of frequency boundaries for the analysis channels of cochlear implants has been shown to impact the speech perception performance of adult recipients (Skinner et al, 1995; Fourakis et al, 2004). While technological limitations heretofore have limited the clinical feasibility of investigating novel frequency assignments, the SPEAR3 research processor affords the opportunity to investigate an unlimited number of possibilities. Here, four different assignments are evaluated using a variety of speech stimuli. All participants accommodated to assignment changes, and no one assignment was significantly preferred. The results suggest that better performance can be achieved using a strategy whereby (1) there are at least 7-8 electrodes allocated below 1000 Hz, (2) the majority of remaining electrodes are allocated between 1100-3000 Hz, and (3) the region above 3 kHz is represented by relatively few electrodes (i.e., 1-3). The results suggest that such frequency assignment flexibility should be made clinically available.

Entities:  

Mesh:

Year:  2007        PMID: 18326156     DOI: 10.3766/jaaa.18.8.7

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  2 in total

1.  Factors affecting open-set word recognition in adults with cochlear implants.

Authors:  Laura K Holden; Charles C Finley; Jill B Firszt; Timothy A Holden; Christine Brenner; Lisa G Potts; Brenda D Gotter; Sallie S Vanderhoof; Karen Mispagel; Gitry Heydebrand; Margaret W Skinner
Journal:  Ear Hear       Date:  2013 May-Jun       Impact factor: 3.570

2.  Use of an adaptive-bandwidth protocol to measure importance functions for simulated cochlear implant frequency channels.

Authors:  Nathaniel A Whitmal; Kristina DeRoy
Journal:  J Acoust Soc Am       Date:  2012-02       Impact factor: 2.482

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.